Company intelligence / Profile preview

Scorpion Capital

Atlanta, Georgia, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Scorpion Capital is a private investment firm and activist short seller, not a life science, biotech, pharma, or healthcare operating company. The firm focuses on investigative short-selling research and publishes reports on publicly traded companies it believes are frauds or promotions. Its public materials emphasize deep-dive due diligence, forensic-style research, and publication of bearish theses. Scorpion Capital has been particularly visible in critiques of healthcare and life sciences companies, but it does not appear to develop therapeutics, diagnostics, or healthcare services itself.

Industry: Investors

Beyond the preview

Go deeper on Scorpion Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scorpion Capital.

Explore the full profile